Dynamics of cellular immunity indicators in the complex treatment of acute optic neuritis

An increase in the incidence of optic neuritis among the working-age population, as well as an unpromising prognosis for vision due to the development of optic nerve atrophy, determines the high social significance of this problem. The aim of the work is to analyze the effect of Imunofan at the parameters of cellular immunity and clinical symptoms of the disease in the complex treatment of optic neuritis associated with herpes virus infection. The study involved 37 people (37 eyes) with acute optic neuritis associated with herpes infection. The treatment regimen included the appointment of a dexamethasone solution according to a decreasing scheme, a 1% solution of the drug Emoxipin 0.5 mL and a 12.5% solution of the drug Dicynone 0.5 mL through an irrigation system implanted in the retrobulbar space, in combination with the neuroprotection drugs (Pikamilon and Semax) for 10 days. All patients were divided into 2 groups. The main group consisted of 20 patients who received Imunofan to the treatment regimen in addition. The comparison group included 17 patients who were treated only according to the method described above. The course of treatment lasted 10 days. The analysis of the data showed a more significant positive dynamics of cellular immunity parameters in those who received immunotherapy. Our studies showed the effectiveness of this drug in the complex treatment of optic neuritis associated with herpes infection, what is confirmed by the acceleration of inflammation relief, a more significant increase in visual functions of patients treated with Imunofan, and a lower percentage of optic nerve atrophy. In this group of patients, changes in the parameters of the cellular link of immunity occurred earlier and remained stable throughout the entire period of observation. According to our data, an intergroup assessment of the immunoregulatory index showed its faster increase in patients of the comparison group who received Imunofan, and reached normal values already 6 months after treatment. The clinical effectiveness of Imunofan in the complex therapy of optic neuritis associated with herpes infection was characterized by a reduction in the period of relief of signs of inflammation in the optic nerve by 2 times or more, by an increase in the maximum corrected visual acuity by 4.5 times, and by a decrease in the incidence of recurrence of optic neuritis by 2 times over a 12 months observation period.

1. Avetisov S.E., Egorov E.A., Moshetova L.K., Neroev V.V., Takhchidi Kh.P. Ophthalmology. National guide. Moscow: GEOTAR-Media, 2019. 752 p.

2. Chernakova G.M., Maychuk D.Yu., Kleshcheva E.A., Loshkareva A.O., Semenova T.B. Guidelines for the management of patients with Herpetic keratitis/keratouveitis in the long term: from problem to solution. Ophthalmology in Russia, 2019, Vol. 16, no. 4, pp. 537-545. (In Russ.)

3. Eliseeva E.K., Neroev V.V., Zueva M.V., Tsapenko I.V., Zakharova M.N. Optic neuritis with multiple sclerosis (review of literature and own data). Point of Miew. East - West, 2018, no. 2, pp. 112-115. (In Russ.)

4. Isakov V.A., Rybalkin S.B., Romantsov M.G. Herpes virus infection. St. Petersburg, 2017. 64 p.

5. Korsakova N.V., Korsakova E.I. Diagnosis and treatment of descending optic neuritis developed as a manifestation of local viral encephalitis (a clinical case). Russian Journal of Clinical Ophthalmology, 2022, Vol. 22, no.4. pp. 273-278. (In Russ.)

6. Krivosheeva M.S., Ioyleva E.E. Modern view on the problem of optic neuritis (systematic review). Saratov Journal of Medical Scientific Research, 2020, Vol. 16, no. 2, pp. 602-605. (In Russ.)

7. Kuznetsova T.I., Astakhov Yu.S. Is it possible to cut down the number of unknown etiology in uveitis? Ophthalmology Journal, 2019, Vol. 12, no. 3, pp. 21-30. (In Russ.)

8. Markelova E.V., Knysh S.V., Nevezhkina T.A., Baibarina E.V. Alphaherpesviruses: the modern look at the viral structure. Pacific Medical Journal, 2018, Vol. 4, no. 74, pp. 5-9. (In Russ.)

9. Povaliaeva D.A., Egorov V.V., Smolyakova G.P., Danilova L.P., Emanova L.P., Zhayvoronok N.S. Herpesviral infection as an etiological factor of acute idiopatic optic neuritis. Bulletin of Ophthalmology, 2019, Vol. 135, no. 2, pp. 4-11. (In Russ.)

10. Povaliaeva D.A., Danilova G.P., Emanova L.P. Clinical-immunological monitoring of etiological structure of idiopathic optic neuritis. Pacific Medical Journal, 2018, Vol. 2, no. 72, pp. 74-77. (In Russ.)

11. Povaliaeva D.A., Egorov V.V., Smoliakova G.P., Danilova L.P. Clinical aspects of using of etiotropic immunotherapy in complex treatment of patients with acute optic neuritis associated with herpesvirus infection. Ophthalmology in Russia, 2018, Vol. 15, no.1, pp. 80-86. (In Russ.)

12. Sdobnikova S.V, Troitskaya N.A., Surnina Z.V., Pateyuk L.S. General and ophthalmic manifestations of herpes virus infections. Ophthalmology in Russia, 2016, Vol. 13, no. 4, pp. 228-234. (In Russ.)

13. Zaynutdinova G.C. Мodem approaches to the treatment and prevention of recurrent of ophthalmic herpes. Review. Ophthalmology in Russia, 2019, Vol. 16, no. S1, pp. 12-20. (In Russ.)